Rx · Prescription onlyTaken by mouth
Naltrexone Low-Dose
Appetite and inflammation.
Your plan
How many capsules per month?
You'll receive 30 capsules per month. $99 billed monthly. Cancel anytime.
- Medication, clinician care and dose adjustments, all in one price.
- ~30-day supply. Your clinician sets your exact dose, so yours may vary; your refill arrives as you finish the last one.
A licensed clinician on our care team reviews every request and prescribes only when it's clinically appropriate.
FDA status: Compounded medication, not FDA-approved.
What it's for
Who it's for
People whose eating is driven by cravings and reward more than by hunger.
How it's different
It acts on the brain's reward signals rather than on digestion. Used off-label and often alongside another treatment.
How it works
Naltrexone is approved as a full-dose medication for opioid and alcohol dependence. At low doses (2.5–5 mg daily), it is prescribed off-label for weight loss and metabolic support. The mechanism for weight loss is not fully understood; proposed pathways include reduced inflammation and altered appetite signaling.
How to use it and what arrives
30 capsules · lasts 1 month
Your clinician sets your dose: 1.5–16 mg · same price at every dose
- How
- Taken by mouth
- How often
- Once a day
- When
- At bedtime
Good to know
It blocks opioid painkillers. Tell every doctor and dentist that you take it before any procedure.
What the research shows
Low-dose naltrexone (usually 4.5 mg) is used off label. No obesity trial of it was found; the weight evidence belongs to a different, higher-dose product, naltrexone with bupropion.
LDN and weight
no trial found
No placebo-controlled trial of low-dose naltrexone for weight in people with obesity was found. Its trials are mostly in other conditions, and a 2026 narrative review says early positive results were rarely replicated.
PubMed search; 2026 narrative reviewNaltrexone with bupropion
different product
The obesity trials that exist are for naltrexone combined with bupropion, a different and higher-dose product. Its figures are not reproduced here because they were not verified for this page.
PubMed search on naltrexone-bupropion trialsFibromyalgia pain
28.8% vs 18.0%
In 31 women with fibromyalgia, 4.5 mg daily reduced daily pain by 28.8%, against 18.0% on placebo, in a randomized crossover trial (Younger et al., Arthritis & Rheumatism 2013).
Younger et al., Arthritis & Rheumatism 2013
No trial in these sources tested low-dose naltrexone for weight. Compounded LDN from pharmacies was not studied, and the combination figures on this page belong to a different product.
What this does not say
- Low-dose naltrexone is used off label; its effect on weight is unknown.
- Naltrexone with bupropion is a separate prescription product with different doses; its results do not transfer.
- The LDN trials that exist are in other diseases, and the fibromyalgia trial had 31 participants; no long-term safety data for weight use was found.
Sources
- Metformin and weight loss: a systematic review of non-diabetic use. Obes Surg, 2017
- Topiramate for weight loss: clinical efficacy and safety review. Drugs Today, 2019
Safety
FDA status: Compounded medication, not FDA-approved.
Side effects and precautions
- Oral weight-loss medications (metformin, naltrexone, topiramate) have different safety profiles.
- Metformin: GI side effects (nausea, diarrhea) common, especially initially; not for severe kidney disease.
- Naltrexone: generally well-tolerated; headache or dizziness possible.
- Topiramate: cognitive effects ('topiramate fog', difficulty concentrating, word-finding) in 10–15%; kidney stones possible.
- All are off-label for weight loss; efficacy and safety are not FDA-approved for this use.
Get care right away
- Stop and seek care for severe GI pain (metformin), severe headache, allergic reactions, or eye pain (topiramate).
Tell your clinician about all medications, kidney disease, and any history of kidney stones (topiramate).
Questions
How does low-dose naltrexone help with weight loss?
The exact mechanism is not clear. Proposed pathways include reduced inflammation, improved appetite regulation, and changes in reward signaling. The evidence is early. Your clinician will assess your response and adjust based on what works for you.
Why are these off-label?
These medications are FDA-approved for other conditions (diabetes, seizures, addiction) but not specifically for weight loss. Off-label use is legal and common; your clinician prescribes based on research and experience.
Which one should I choose?
That depends on your health profile, goals, and what side effects you can tolerate. Metformin is gentlest but least effective. Naltrexone is experimental. Topiramate is moderate. Your clinician will recommend based on your individual needs.
Can I combine these with GLP-1 drugs?
Yes, some combinations are used; for example, topiramate plus phentermine. However, combining multiple weight-loss medications requires careful clinician oversight.
What if these don't work?
If you see minimal effect after 8–12 weeks, your clinician may increase the dose, switch medications, or recommend GLP-1 drugs like semaglutide or tirzepatide for stronger effect.
Ready to start with Naltrexone Low-Dose?
$99/mo · $99 billed every month
- Free shipping on every order
- No membership fee
- Same price at every dose
- HSA and FSA accepted
More options in this area
Semaglutide + Glycine
Medical weight management
From $99 · 4-week supply
6 strengths · 250 mcg – 2.5 mg
